Literature DB >> 29348731

Problems with precaution: the transfusion medicine experience.

Kumanan Wilson1,2, Katherine M Atkinson1,3, Dean A Fergusson1,4, Adalsteinn Brown5, Alan Forster1,6, Malia S Q Murphy1, Alan T Tinmouth1,6, Jennifer Keelan7.   

Abstract

The precautionary principle is a dominant paradigm governing risk-based decision-making. Today, there are increasing pressures to re-examine aggressive precautionary approaches, and to assess how the principle should be applied in the modern system. In this paper, we examined three key applications of precautionary approaches in the field of transfusion medicine to provide insight into the risks and benefits of these approaches. The three case studies examined were the donor deferral policies to safeguard against transfusion transmission of human immunodeficiency virus, variant Creutzfeldt-Jacob disease, and, lastly, xenotropic murine leukemia virus-related virus. Characterization of precautionary applications was conducted using an embedded case study design. Our findings indicate that transfusion transmission mitigation strategies have become increasingly aggressive in the face of theoretical risks. In contrast, the review processes for implementation and reversal of precautionary policies have been slow, and historical donor deferral policies are still in place today. Application of precautionary approaches has proved challenging with both benefits and pitfalls. In light of emerging threats to the blood system, policy-makers should consider the implementation of frameworks to guide the appropriate application of precaution in transfusion medicine in the future.

Entities:  

Keywords:  Blood transfusion; donor exclusion; precautionary principle; risk–benefit assessment

Year:  2017        PMID: 29348731      PMCID: PMC5770215          DOI: 10.1080/13669877.2017.1351478

Source DB:  PubMed          Journal:  J Risk Res        ISSN: 1366-9877


  51 in total

1.  Precaution without principle.

Authors:  H I Miller; G Conko
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

2.  Application of the precautionary principle by senior policy officials: results of a Canadian survey.

Authors:  Kumanan Wilson; Blair Leonard; Robert Wright; Ian Graham; John Moffet; Michael Pluscauskas; Michael Wilson
Journal:  Risk Anal       Date:  2006-08       Impact factor: 4.000

3.  The Krever Commission--10 years later.

Authors:  Kumanan Wilson
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

4.  Evidence-Based Policy and Practice Leads to Changes in the Criteria for MSM to Donate Blood.

Authors:  Anne Slowther; Nicholas A Watkins; Deirdre Kelly
Journal:  Transfus Med Hemother       Date:  2013-05-17       Impact factor: 3.747

5.  The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

Authors:  P Brown; R G Rohwer; B C Dunstan; C MacAuley; D C Gajdusek; W N Drohan
Journal:  Transfusion       Date:  1998-09       Impact factor: 3.157

6.  Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

Authors:  Julie Ann Edgeworth; Michael Farmer; Anita Sicilia; Paul Tavares; Jonathan Beck; Tracy Campbell; Jessica Lowe; Simon Mead; Peter Rudge; John Collinge; Graham S Jackson
Journal:  Lancet       Date:  2011-02-05       Impact factor: 79.321

7.  Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety.

Authors:  Roger Y Dodd; John Hackett; Jeffrey M Linnen; Kerri Dorsey; Yanyun Wu; Shimian Zou; Xiaoxing Qiu; Priscilla Swanson; Gerald Schochetman; Kui Gao; James M Carrick; David E Krysztof; Susan L Stramer
Journal:  Transfusion       Date:  2011-11-21       Impact factor: 3.157

8.  Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.

Authors:  A Peden; L McCardle; M W Head; S Love; H J T Ward; S N Cousens; D M Keeling; C M Millar; F G H Hill; J W Ironside
Journal:  Haemophilia       Date:  2010-01-12       Impact factor: 4.287

9.  The use of preliminary scientific evidence in public health: a case study of XMRV.

Authors:  Kumanan Wilson; Katherine Atkinson; Jennifer Keelan
Journal:  PLoS Med       Date:  2014-04-08       Impact factor: 11.069

10.  Variant Creutzfeldt-Jakob disease and the Canadian blood system after the tainted blood tragedy.

Authors:  Kumanan Wilson; Ian Graham; Maura Ricketts; Christopher Dornan; Andreas Laupacis; Paul Hebert
Journal:  Soc Sci Med       Date:  2006-10-02       Impact factor: 4.634

View more
  1 in total

1.  Transfusion medicine: Overtime paradigm changes and emerging paradoxes.

Authors:  O Garraud; T Vuk; M Lozano; J-D Tissot
Journal:  Transfus Clin Biol       Date:  2020-10-06       Impact factor: 1.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.